ALEMBIC PHARMACEUTICALS LTD.

NSE : APLLTDBSE : 533573ISIN CODE : INE901L01018Industry : Pharmaceuticals & DrugsHouse : Alembic
BSE995.0544.2 (+4.65 %)
PREV CLOSE ( ) 950.85
OPEN PRICE ( ) 969.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5843
TODAY'S LOW / HIGH ( )961.45 1006.50
52 WK LOW / HIGH ( )536.6 1093.05
NSE997.5039.5 (+4.12 %)
PREV CLOSE( ) 958.00
OPEN PRICE ( ) 961.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 997.50 (320)
VOLUME 136404
TODAY'S LOW / HIGH( ) 955.80 1010.00
52 WK LOW / HIGH ( )537.75 1094
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.